5 questions about NIH licenses to patents on Production of Attenuated Respiratory Syncytial Virus Vaccines

The NIH has a notice for comments on proposed licenses of several patents relating to the “Production of Attenuated Respiratory Syncytial Virus Vaccines”. See: https://federalregister.gov/a/2016-03486

We asked Peter Soukas, a Senior Technology Licensing Specialist in the Technology Transfer and Intellectual Property Office, at the National Institute of Allergy and Infectious Diseases (NIAID), these questions:

  1. What provisions exist in the license to protect US residents against excessive or unreasonable pricing?
  2. Continue Reading

Uncategorized

KEI comments to Copyright Office on software-enabled consumer products

Submission of Knowledge Ecology International
U.S. Copyright Office Docket No. 2015-6

This is the submission of Knowledge Ecology International (KEI) in response to the U.S. Copyright Office request for public comment on “software-enabled consumer products” (U.S. Copyright Office Docket No. 2015-6).

Introduction

Knowledge Ecology International is a non-governmental organization with offices in Washington, DC, and Geneva, Switzerland, that searches for better outcomes, including new solutions, to the management of knowledge resources.

This submission covers these topics:

    Continue Reading

Uncategorized

WTO TRIPS Council (March 2016) to discuss Intellectual Property and Innovation: Education and Diffusion

The World Trade Organization (WTO) will convene its Council for TRIPS (TRIPS Council) from Tuesday, 1 March 2016 to Wednesday, 2 March 2016. Australia, the European Union, Switzerland and the United States of America have submitted a written request for the item “Intellectual Property and Innovation: Education and Diffusion” to be placed on the proposed agenda.

WTO/AIR/IP/6
5 FEBRUARY 2016

SUBJECT: COUNCIL FOR TRIPS

THE NEXT MEETING OF THE COUNCIL FOR TRIPS WILL BE HELD IN THE CENTRE WILLIAM RAPPARD ON 1-2 MARCH 2016. THE MEETING WILL START AT
Continue Reading

Uncategorized

Obama asks the Senate to ratify the Marrakesh treaty for the blind

This is the announcement.

For Immediate Release February 10, 2016

TO THE SENATE OF THE UNITED STATES:

With a view to receiving the advice and consent of the Senate to ratification, I transmit herewith the Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired, or Otherwise Print Disabled, done at Marrakesh on June 27, 2013 (Marrakesh Treaty). I also transmit, for the information of the Senate, a report of the Secretary of State with respect to the Marrakesh Treaty that includes a summary of its provisions.

Continue Reading

Uncategorized

Feasibility study on a TDR pooled fund for R&D to be released on 20 February 2016

In May 2014, the 67th World Health Assembly (WHA) of the World Health Organization (WHO) passed Decision WHA67(15) providing WHO the mandate to explore the feasibility of creating a voluntary pooled fund fund on R&D hosted by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The Decision outlined three principles guiding the consideration of the pooled fund:

Continue Reading

Uncategorized

Xtandi 2016 March-In Request

Today Knowledge Ecology International and the Union for Affordable Cancer Treatment (UACT) petitioned the Department of Health and Human Services, the Department of Defense, and the National Institutes of Health, asking that they exercise either their royalty-free, non-exclusive license or federal “march-in” rights to end the monopoly on an expensive prostate cancer drug, enzalutamide, marketed as Xtandi by Astellas, a Japanese pharmaceutical company.

Xtandi was invented at UCLA on federal grants from the NIH and DoD.

Continue Reading